Allogeneic hematopoietic cell transplantation in systemic mastocytosis: Is there a high risk for veno-occlusive disease?

European Journal of Haematology

Volumn 96, Issue 6, 2016, Pages 655-657

  Smith, Angela ^a   Cayci, Zuzan ^a   Courville, Elizabeth L ^b   Corbacioglu, Selim ^c   Akin, Cem ^d   Horny, Hans Peter ^e   Valent, Peter ^f   Devine, Steven ^g   Weisdorf, Daniel J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF MUNICH   (Germany)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN GLUCURONIDE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; ANTITHROMBOCYTIC AGENT; DEFIBROTIDE; POLYDEOXYRIBONUCLEOTIDE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ASCITES; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIURETIC THERAPY; DOPPLER FLOWMETRY; EDITORIAL; GRAFT VERSUS HOST REACTION; HUMAN; LIVER SIZE; MALE; MIDDLE AGED; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; ULTRASOUND; VEIN OCCLUSION; ADVERSE EFFECTS; ALLOTRANSPLANTATION; COMPLICATION; DIAGNOSTIC IMAGING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; MASTOCYTOSIS, SYSTEMIC; PROCEDURES; PULMONARY VENO-OCCLUSIVE DISEASE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VASCULAR DISEASES;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MALE; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POLYDEOXYRIBONUCLEOTIDES; PULMONARY VENO-OCCLUSIVE DISEASE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 84955609959     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12720     Document Type: Editorial

References (14)

1. Ustun C, Reiter A, Scott BL, et al. Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. J Clin Oncol 2014;32:3264-74.
2. Carreras E, Rosinol L, Terol MJ, et al. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. Biol Blood Marrow Transplant 2007;13:1448-54.
3. Ustun C, Cayci Z, Courville E. A patient with skin lesions, osteosclerosis and hepatosplenomegaly. Br J Haematol 2014;167:291.
4. Randall N, Courville EL, Baughn L, Afrin L, Ustun C. Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis. Am J Hematol 2015;90:E74.
5. Mican J, Metcalfe DD. Liver-disease in systemic mastocytosis (SM). J Allergy Clin Immunol 1992;89:268-268.
6. Metcalfe DD. The liver, spleen, and lymph-nodes in mastocytosis. J Invest Dermatol 1991;96:S45-6.
7. Horny HP, Kaiserling E, Campbell M, Parwaresch MR, Lennert K. Liver findings in generalized mastocytosis - a clinicopathologic study. Cancer 1989;63:532-8.
8. Bunte MC, Patnaik MM, Pritzker MR, Burns LJ. Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. Bone Marrow Transplant 2008;41:677-86.
9. Mandel J, Mark EJ, Hales CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 2000;162:1964-73.
10. Resten A, Maitre S, Humbert M, et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. Am J Roent 2004;183:65-70.
11. Schmidt M, Dercken C, Loke O, et al. Pulmonary manifestation of systemic mast cell disease. Eur Respir J 2000;15:623-5.
12. Huang TY, Yam LT, Li CY. Radiological features of systemic mast-cell disease. Br J Radiol 1987;60:765-70.
13. Mitani Y, Ueda M, Maruyama K, et al. Mast cell in pulmonary hypertension. Thorax 1999;54:88-90.
14. Valent P, Baghestanian M, Bankl HC, et al. New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells. Thromb Haemost 2002;87:786-90.